×
About 853 results

ALLMedicine™ Lipid Disorders Center

Research & Reviews  273 results

Genes Involved in Lipid Disorders
https://clinicaltrials.gov/ct2/show/NCT02311335

May 20th, 2022 - The primary purpose of this discovery protocol is to identify new lipid genes from subjects with rare genetic lipids disorders. We will take advantage of the new technology of whole exome sequencing to find the cause of dyslipidemia that we haven ...

Screening for Albuminuria at the First Line for Early Identification of CKD
https://clinicaltrials.gov/ct2/show/NCT05321095

May 5th, 2022 - Early detection and appropriate treatment of kidney disease is important as this may prevent future cardiovascular complications and end-organ damage more effectively than intervention in more advanced stages of disease. There is a well-establishe...

Part I Cutaneous Manifestations of Cardiovascular Disease.
https://doi.org/10.1016/j.jaad.2021.06.902
Journal of the American Academy of Dermatology; Karch J, Raja A et. al.

May 4th, 2022 - In this Part 1 of a 2-part continuing medical education series, we review the epidemiology and pathophysiology of cardiovascular disease, its association with cutaneous symptoms, and the diagnosis and evaluation of cutaneous features of cardiovasc...

Dyslipidemia Management in Pregnancy: Why Is It not Covered in the Guidelines?
https://doi.org/10.1007/s11883-022-01030-w 10.1093/eurjpc/zwaa047 10.5114/aoms/141941 10.1016/j.siny.2009.04.002 10.1210/jc.2012-1295 10.1111/j.1471-0528.1979.tb11240.x 10.1016/0002-9378(88)90574-1 10.1152/jappl.1999.87.1.196 10.1016/S0021-9150(01)00734-1 10.1016/S0002-9378(99)70574-0 10.1007/s10815-019-01523-9 10.1097/MD.0000000000026786 10.3389/fphar.2021.715302 10.1016/j.atherosclerosis.2006.01.002 10.1016/j.numecd.2017.05.005 10.1186/s12884-016-0852-9 10.1136/bmjopen-2016-013509 10.2174/1871530319666190529090517 10.1111/obr.12693 10.1016/j.ajog.2009.05.032 10.2337/db18-1308 10.1186/s12944-020-01316-5 10.1186/s12944-020-01398-1 10.1186/s12916-020-01868-4 10.1016/S0140-6736(99)02131-5 10.1001/jama.1991.03460140086032 10.1016/j.pcad.2020.04.004 10.1016/j.mehy.2004.04.026 10.1016/S0140-6736(03)12771-7 10.1093/eurheartj/ehy340 10.1161/JAHA.119.015123 10.1093/eurheartj/ehz455 10.1136/bmj.j3119 10.1161/JAHA.120.016052 10.1002/j.1552-4604.1990.tb03447.x 10.1161/01.CIR.69.2.313 10.1161/01.CIR.69.2.325 10.1056/NEJM198101293040502 10.3390/nu9030197 10.1093/ajcn/87.6.1981S 10.1517/14656566.9.7.1237 10.1056/NEJMoa1811403 10.1056/NEJMoa1804989 10.1056/NEJMoa1812792 10.1002/tera.1420280316 10.1002/tera.1420500604 10.1016/0140-6736(92)91237-3 10.1056/NEJM200404083501524 10.1016/S1701-2163(15)30565-X 10.1016/j.jacl.2016.07.002 10.1080/13543784.2018.1465927 10.1161/CIRCULATIONAHA.121.053963 10.1016/j.atherosclerosis.2018.05.038 10.1016/j.atherosclerosis.2021.05.006 10.1016/j.jacl.2015.11.011 10.1002/bdr2.1930 10.1001/jamacardio.2019.3502 10.1007/s11883-021-00968-7 10.1016/j.atherosclerosissup.2012.10.021 10.1016/j.atherosclerosis.2016.10.017 10.1046/j.1526-0968.2003.00066.x 10.1007/s11789-012-0042-x 10.1007/s00404-013-2786-z 10.1111/1744-9987.12022 10.1016/j.transci.2015.11.008 10.1016/j.jacc.2018.11.002
Current Atherosclerosis Reports; Lewek J, Banach M

May 3rd, 2022 - Despite the elevation of lipid values during pregnancy is mostly physiological, evidence suggest that it may be associated with adverse events. This article reviews the characteristics of lipid disorders and the possible management with dyslipidem...

Characteristics of participants who take up screening tests for diabetes and lipid diso...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058764
BMJ Open; Ding H, Huang J et. al.

Apr 30th, 2022 - To perform a systematic review on the characteristics of participants who attended screening programmes with blood glucose tests, lipid profiles or a combination of them, respectively. Systematic review following the Meta-analysis Of Observational...

see more →

Guidelines  3 results

Screening for Lipid Disorders in Children and Adolescents: Recommendation Statement.
https://www.ncbi.nlm.nih.gov/pubmed/28075093
American Family Physician;

Jan 12th, 2017 - Screening for Lipid Disorders in Children and Adolescents: Recommendation Statement.|2017||therapeutic use,diagnosis,therapy,diagnosis,drug therapy,

Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventiv...
https://doi.org/10.1001/jama.2016.15450
JAMA , Bibbins-Domingo K et. al.

Nov 14th, 2016 - Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in the United States, accounting for 1 of every 3 deaths among adults. To update the 2008 US Preventive Services Task Force (USPSTF) recommendation on screening for lipid...

Screening for Lipid Disorders in Children and Adolescents: US Preventive Services Task ...
https://doi.org/10.1001/jama.2016.9852
JAMA , Bibbins-Domingo K et. al.

Aug 18th, 2016 - Elevations in levels of total, low-density lipoprotein, and non-high-density lipoprotein cholesterol; lower levels of high-density lipoprotein cholesterol; and, to a lesser extent, elevated triglyceride levels are associated with risk of cardiovas...

see more →

Drugs  1 results see all →

Clinicaltrials.gov  8 results

Genes Involved in Lipid Disorders
https://clinicaltrials.gov/ct2/show/NCT02311335

May 20th, 2022 - The primary purpose of this discovery protocol is to identify new lipid genes from subjects with rare genetic lipids disorders. We will take advantage of the new technology of whole exome sequencing to find the cause of dyslipidemia that we haven ...

Screening for Albuminuria at the First Line for Early Identification of CKD
https://clinicaltrials.gov/ct2/show/NCT05321095

May 5th, 2022 - Early detection and appropriate treatment of kidney disease is important as this may prevent future cardiovascular complications and end-organ damage more effectively than intervention in more advanced stages of disease. There is a well-establishe...

Non-invasive Monitoring for Early Detection of Atrial Fibrillation
https://clinicaltrials.gov/ct2/show/NCT03243474

Apr 2nd, 2019 - The AF Survey is a cross-sectional observational study aimed to assess the prevalence and control of AF and its correlation with CVD risk factors in Poland, based on a representative sample of adults aged 65+. The main aim of the survey is to asse...

FFA-Induced Hypertension and Endothelial Dysfunction
https://clinicaltrials.gov/ct2/show/NCT00589888

Oct 16th, 2018 - Insulin resistance has been implicated as the central mechanism in the development of several cardiovascular risk factors including hypertension, diabetes, lipid disorders, and coagulation disorders. Recent evidence suggests that increased levels ...

Thyroid Dysfunction and Dyslipidemia in Patients With Chronic Kidney Diseases
https://clinicaltrials.gov/ct2/show/NCT03277911

Sep 11th, 2017 - Chronic kidney disease[CKD] is becoming a serious health problem.The number of people with impaired renal function is rapidly rising, especially in industrialized countries. It is increasing rapidly worldwide at an annual growth rate of 8%. Chroni...

see more →

News  56 results

Tirzepatide (Mounjaro) Gets FDA Approval for Type 2 Diabetes
https://www.medscape.com/viewarticle/974013

May 13th, 2022 - The "Twincretin" era for treating patients with type 2 diabetes has begun, with the US Food and Drug Administration's (FDA's) approval of tirzepatide for this indication on May 13, making it the first approved agent that works as a dual agonist fo...

Time to Cut Bait on Omega-3's Neuroprotective Claims
https://www.medscape.com/viewarticle/966683

Feb 2nd, 2022 - This transcript has been edited for clarity. Dear colleagues, I'm Christoph Diener from the University of Duisburg-Essen in Germany. This month I'm deviating from what I usually do, which is reporting a handful of recent studies that may impact yo...

Cognitive Function in Diabetes: How to Protect Our Patients
https://www.medscape.com/viewarticle/945285

Feb 10th, 2021 - People with diabetes pose a particular challenge when trying to assess cognitive function longitudinally. Population data suggest that the risk of developing dementia, both vascular and neurodegenerative, among people with diabetes followed for 20...

AACE Issues 'Cookbook' Algorithm to Manage Dyslipidemia
https://www.medscape.com/viewarticle/939982

Oct 29th, 2020 - Dr Yehuda Handelsman A new algorithm on lipid management and prevention of cardiovascular disease from the American Association of Clinical Endocrinologists* (AACE) and the American College of Endocrinology (ACE) is "a nice cookbook" that many cli...

'Biosimilar' Insulin Glargine, Semglee, Approved for Diabetes in US
https://www.medscape.com/viewarticle/932275

Jun 13th, 2020 - Semglee, a long-acting human insulin analogue, has been approved for glycemic control in adults and children with type 1 diabetes and adults with type 2 diabetes, the Food and Drug Administration announced June 11. "Long-acting insulin products li...

see more →